Tobias R. Overbeck
Robert Koch Str. 40
Goettingen, NI 37075, Germany
Goettingen, NI 37075, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320).
Journal: JAMA oncology
Published: July 09, 2026
Palliative Systemic Therapy in Advanced Thymic Epithelial Tumors in 2026-A Narrative Review.
Journal: Cancers
Published: June 05, 2026
Reducing prescription errors in oncological systemic therapies by implementing software-assisted therapy planning
Journal: Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
Published: February 10, 2026
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 13, 2025
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 13, 2025
Clinical management and outcomes of relapsed NSCLC after chemoradiotherapy and durvalumab consolidation: real-world evidence from Germany.
Journal: Therapeutic advances in medical oncology
Published: November 07, 2025
PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 08, 2025
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.
Journal: NPJ precision oncology
Published: September 05, 2025
Impact of radiation dose on immune cells (EDIC) on oncologic outcome in small cell lung cancer (SCLC).
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: May 02, 2025
Proteasome inhibition as a potential therapeutic target in thymic cancer.
Journal: Cell death & disease
Published: January 08, 2025
Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC.
Journal: BMC cancer
Published: November 22, 2024
Last Updated: 09/26/2026